James P. Steinberg

TL;DR: These guidelines were developed jointly by the American Society of Health-System Pharmacists (ASHP), the Infectious Diseases Society of America, the Surgical Infection Society (SIS), and the Society for Healthcare Epidemiology of America (SHEA).

TL;DR: The guidelines were developed jointly by the American Society of Health-System Pharmacists (ASHP), the Infectious Diseases Society of America (IDSA), the Surgical Infection Society (SIS), and the Society for Healthcare Epidemiology (SHEA) as mentioned in this paper.

TL;DR: It is found that in chronic HCV infection, peripheral HCV-specific T cells express high levels ofPD-1 and that blockade of the PD-1/PD-L1 interaction led to an enhanced proliferative capacity.

TL;DR: These data from a large multicenter collaborative study confirm and extend previous observations and show a consistent relationship between the timing of AMP and SSI risk with a trend toward lower risk occurring when AMP with cephalosporins and other antibiotics with short infusion times were given within 30 minutes prior to incision.

TL;DR: The rate of nosocomial bacteremia due to Staphylococcus aureus has increased over the past decade, but trends in community-acquired S. a Aureus bacterenmia are less certain, and MRSA and intravascular device-related S.Aureus b acteremias are emerging problems in the nonhospital setting.